Clinical Genetics · 1994 · 22 citations · 11 references
MedicineEndocrinologyObstetricsMaternal-fetal MedicinePrenatal DiagnosisReproductive EndocrinologyHormonal EvaluationPregnancyPregnancy DiagnosisPregnancy EndocrinologyPrenatal Genetic DiagnosisPrenatal Molecular TestingAssayAssay OptimizationBlood Pregnancy TestingMaternal Serum Alpha-fetoprotein ScreeningPrenatal Diagnosis Of Down SyndromePrenatal Screening Markers
We have evaluated a simple and rapid 2-step dual-label assay (DELFIA) for alphafetoprotein (AFP) and free beta subunit of human gonadotropin (hCG beta) in second-trimester screening for Down syndrome. Based on stored serum samples from 1059 normal control pregnancies and 72 cases of Down syndrome, we have found the mean Multiple of Median (MoM) for AFP and free hCG beta to be 0.70 and 2.31, respectively. This is slightly but not significantly better than the values for the separate assay for AFP (0.76 MoM) and for intact hCG (2.11 MoM). However, the dual assay is much simpler than the separate assays and therefore prospective comparison trials should be carried out.
11
Maternal serum screening for Down's syndrome in early pregnancy.
N J Wald, Howard Cuckle, J. W. Densem et al. · BMJ · 1988 · 974 citations · Full text
Kevin Spencer, E.J. Coombes, Angela S. Mallard et al. · Annals of Clinical Biochemistry International Journal of Laboratory Medicine · 1992 · 188 citations
Medicine, Endocrinology, Obstetrics +15